ArticleJournal of molecular medicine (Berlin, Germany)2021
MT1 and MT2 melatonin receptors play opposite roles in brain cancer progression.
G S Kinker et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it